icon-nav-help
Need Help

Submit your question to our team of health care professionals.

icon-nav-current-questions
Current Question

See what's on the mind of the community right now.

icon-conf-speakers-at-a-glance
Meet the Team

Learn more about our world-renowned team.

icon-nav-archives
CWD Answers Archives

Review the entire archive according to the date it was posted.

CWD_Answers_Icon
August 18, 2002

Other Medications

advertisement
Question from Dallas, Pennsylvania, USA:

What effect does the use of growth hormone (Somatropin) have on the pancreas? Is it possible for overdosages to trigger type 1 diabetes earlier than it’s naturally destined time frame? Could it affect somatostatin, the hormone made by the delta cells?

Answer:

From: DTeam Staff

There is evidence that growth hormone levels tend to be somewhat high in type 1A (autoimmune), but that there is some degree of growth hormone resistance at the same time. This is perhaps why growth hormone administration does not seem to significantly hasten insulin dependence or to diminish control. Growth hormone does seem to promote type 2 diabetes, however.

Growth hormone and somatostatin both diminish glucose tolerance, but through different mechanisms. Somatostatin and its analogs like Octreotide have been used successfully in treating PHHI (Persistant Hyperinsulinemic Hypoglycemia of Infancy).

DOB